Retour
53
36
11
4
20
Également cotée sous
CHGCY
OTC
Fourchette du Jour
53,31 €
64,01 €
Fourchette 52 Semaines
38,76 €
72,30 €
Volume
216
Moyenne 50J / 200J
58,19 €
/
51,05 €
Clôture Précédente
51,94 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,2 | 0,3 |
| P/B | 0,0 | 3,0 |
| ROE % | 22,1 | 3,7 |
| Net Margin % | 34,5 | 3,8 |
| Rev Growth 5Y % | 5,9 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
531,16 €
488,31 € – 574,26 €
|
1,92T | 5 |
| FY2029 |
481,84 €
442,97 € – 520,94 €
|
1,86T | 2 |
| FY2028 |
392,11 €
360,48 € – 423,93 €
|
1,62T | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-29 | 74,04 € | 0,50 € | -99,3% |
| 2025-07-24 | 0,51 € | 0,41 € | -20,7% |
| 2025-04-24 | 0,34 € | 0,41 € | +21,7% |
| 2025-01-30 | 0,00 € | 0,36 € | +14933,5% |
| 2024-10-25 | 0,45 € | 0,44 € | -2,9% |
| 2024-07-25 | 0,34 € | 0,44 € | +30,2% |
| 2024-04-24 | 0,27 € | 0,29 € | +5,4% |
| 2024-02-01 | 0,33 € | 0,38 € | +15,2% |
Dividend History
Yield
0,02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 5,93% annually over 5 years — modest growth
ROE of 22,11% indicates high profitability
Net margin of 34,50% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 313,45B in free cash flow
P/E of 0,20 — trading at a low valuation
Croissance
Revenue Growth (5Y)
5,93%
Revenue (1Y)7,55%
Earnings (1Y)12,15%
FCF Growth (3Y)-3,37%
Qualité
Return on Equity
22,11%
ROIC21,85%
Net Margin34,50%
Op. Margin46,92%
Sécurité
Debt / Equity
0,00
Current Ratio4,23
Interest Coverage575,24
Valorisation
P/E Ratio
0,20
Forward P/EN/A
P/B Ratio0,04
EV/EBITDA-0,57
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,55% | Revenue Growth (3Y) | 6,44% |
| Earnings Growth (1Y) | 12,15% | Earnings Growth (3Y) | 15,53% |
| Revenue Growth (5Y) | 5,93% | Earnings Growth (5Y) | 9,42% |
| Profitability | |||
| Revenue (TTM) | 1,26T | Net Income (TTM) | 434,39B |
| ROE | 22,11% | ROA | 17,58% |
| Gross Margin | 71,09% | Operating Margin | 46,92% |
| Net Margin | 34,50% | Free Cash Flow (TTM) | 313,45B |
| ROIC | 21,85% | FCF Growth (3Y) | -3,37% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 4,23 |
| Interest Coverage | 575,24 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0,20 | Forward P/E | N/A |
| P/B Ratio | 0,04 | P/S Ratio | 0,07 |
| PEG Ratio | 2,68 | Forward PEG | N/A |
| EV/EBITDA | -0,57 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 357,31% | ||
| Market Cap | 87,72B | Enterprise Value | -339,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,26T | 1,17T | 1,11T | 1,26T | 999,76B |
| Net Income | 434,39B | 387,32B | 325,47B | 374,43B | 303,00B |
| EPS (Diluted) | 263,95 | 235,36 | 197,80 | 227,57 | 184,17 |
| Gross Profit | 895,03B | 831,20B | 698,06B | 783,70B | 661,61B |
| Operating Income | 590,71B | 542,00B | 439,17B | 533,31B | 421,90B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,47T | 2,21T | 1,93T | 1,87T | 1,54T |
| Total Liabilities | 443,25B | 306,87B | 306,97B | 445,37B | 350,68B |
| Shareholders' Equity | 2,03T | 1,90T | 1,63T | 1,42T | 1,19T |
| Total Debt | 0,0 | 10,90B | 13,46B | 14,11B | 16,04B |
| Cash & Equivalents | 426,97B | 540,20B | 458,67B | 222,17B | 267,75B |
| Current Assets | 1,74T | 1,61T | 1,37T | 1,34T | 1,06T |
| Current Liabilities | 411,44B | 290,36B | 288,22B | 423,73B | 327,42B |
Scores de Stratégies
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#45 of 218
#518 of 827
#539 of 670
#639 of 709
#193 of 203
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026